|
CCDC15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.719300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.844000E-04 |
| Normal-vs-Stage2 |
3.334200E-02 |
| Normal-vs-Stage3 |
1.286800E-01 |
| Normal-vs-Stage4 |
7.588200E-02 |
| Stage1-vs-Stage2 |
6.740000E-01 |
| Stage1-vs-Stage3 |
3.237800E-02 |
| Stage1-vs-Stage4 |
1.610190E-01 |
| Stage2-vs-Stage3 |
2.987400E-01 |
| Stage2-vs-Stage4 |
5.274400E-01 |
| Stage3-vs-Stage4 |
6.852800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.625000E-04 |
| Normal-vs-AfricanAmerican |
6.411600E-01 |
| Normal-vs-Asian |
5.047800E-01 |
| Caucasian-vs-AfricanAmerican |
6.281100E-03 |
| Caucasian-vs-Asian |
6.184600E-01 |
| AfricanAmerican-vs-Asian |
6.329600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.045790E-02 |
| Normal-vs-Female |
1.198190E-03 |
| Male-vs-Female |
3.080600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.666200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.767300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.252000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.757000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.512000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.288000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.207600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.346000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.023440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.173200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.158090E-03 |
| Normal-vs-Grade 2 |
7.96330000000234E-05 |
| Normal-vs-Grade 3 |
5.470200E-02 |
| Normal-vs-Grade 4 |
2.286600E-01 |
| Grade 1-vs-Grade 2 |
2.150400E-01 |
| Grade 1-vs-Grade 3 |
8.436300E-03 |
| Grade 1-vs-Grade 4 |
3.079900E-02 |
| Grade 2-vs-Grade 3 |
3.903300E-03 |
| Grade 2-vs-Grade 4 |
3.183500E-02 |
| Grade 3-vs-Grade 4 |
7.857600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.69289999998978E-06 |
| Normal-vs-ccB subtype |
8.241700E-02 |
| ccA subtype-vs-ccB subtype |
8.556900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.459500E-03 |
| Normal-vs-N1 |
7.502800E-01 |
| N0-vs-N1 |
2.459400E-01 |
|
|
